← Every company

Eli Lilly and Co SEC Filings

What Eli Lilly and Co has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

LLY overview →
Filings on file
135
since Oct 25, 2016
Warning signs
0
none filed
Last results
Aug 5, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Nov 7, 2025
Tender offer
SC TO-T
Read ↗
Jun 25, 2025
Tender offer
SC TO-T
Read ↗
Jul 19, 2024
Tender offer
SC TO-T
Read ↗
Oct 13, 2023
Tender offer
SC TO-T
Read ↗
Jul 13, 2023
Tender offer
SC TO-T
Read ↗
Jun 30, 2023
Tender offer
SC TO-T
Read ↗
Oct 31, 2022
Tender offer
SC TO-T
Read ↗
Dec 22, 2020
Tender offer
SC TO-T
Read ↗
Jan 22, 2020
Tender offer
SC TO-T
Read ↗
Mar 15, 2019
Acquisition or sale completed
8-K
Read ↗
Feb 8, 2019
Tender offer
SC TO-I
Read ↗
Jan 17, 2019
Tender offer
SC TO-T
Read ↗
May 23, 2018
Tender offer
SC TO-T
Read ↗
Jan 31, 2017
Tender offer
SC TO-T
Read ↗

Source: Eli Lilly and Co's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on LLY

Related datasets